| Literature DB >> 34367535 |
Peng Bian1, Xiyu Zhang1, Ruihong Liu1, Huijie Li1, Qingqing Zhang1, Baoling Dai2.
Abstract
The neural network algorithm of deep learning was applied to optimize and improve color Doppler ultrasound images, which was used for the research on elderly patients with chronic heart failure (CHF) complicated with sarcopenia, so as to analyze the effect of the deep-learning-based color Doppler ultrasound image on the diagnosis of CHF. 259 patients were selected randomly in this study, who were admitted to hospital from October 2017 to March 2020 and were diagnosed with sarcopenia. Then, all of them underwent cardiac ultrasound examination and were divided into two groups according to whether deep learning technology was used for image processing or not. A group of routine unprocessed images was set as the control group, and the images processed by deep learning were set as the experimental group. The results of color Doppler images before and after processing were analyzed and compared; that is, the processed images of the experimental group were clearer and had higher resolution than the unprocessed images of the control group, with the peak signal-to-noise ratio (PSNR) = 20 and structural similarity index measure (SSIM) = 0.09; the similarity between the final diagnosis results and the examination results of the experimental group (93.5%) was higher than that of the control group (87.0%), and the comparison was statistically significant (P < 0.05); among all the patients diagnosed with sarcopenia, 88.9% were also eventually diagnosed with CHF and only a small part of them were diagnosed with other diseases, with statistical significance (P < 0.05). In conclusion, deep learning technology had certain application value in processing color Doppler ultrasound images. Although there was no obvious difference between the color Doppler ultrasound images before and after processing, they could all make a better diagnosis. Moreover, the research results showed the correlation between CHF and sarcopenia.Entities:
Year: 2021 PMID: 34367535 PMCID: PMC8346313 DOI: 10.1155/2021/2603842
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 2.682
Diagnostic criteria for AWGS sarcopenia.
| Evaluation content | Gender | Criteria | |
|---|---|---|---|
| One | The mass of skeletal muscle measured by the dual energy X-ray absorption method; calculation of the ratio of the mass to the height square | Male | <7.0 kg/m2 |
| Female | <5.4 kg/m2 | ||
|
| |||
| Two | Grip strength | Male | <26 kg |
| Female | <18 kg | ||
| Walking speed | 6-minute walking speed | <0.8 m/s | |
Note. Patients who met any of these criteria could be diagnosed with sarcopenia.
Figure 1Diagnostic criteria for CHF.
Figure 2Comparison on cardiac color ultrasound images before and after optimization by convolutional neural network algorithm.
Figure 3Comparison on cardiac color ultrasound images of CHF patients between the two groups. (a) Control group; (b) experimental group.
Figure 4Comparison on cardiac color ultrasound images between the two groups of patients with other heart diseases. (a) Control group; (b) experimental group.
Statistical results of LVEF, LCDD, and LAD diagnosed by using a cardiac ultrasound in the two groups.
| Indicators | Group | |
|---|---|---|
| Control group | Experimental group | |
| LVEF (%) | 54.05 ± 4.79 | 60.09 ± 4.34 |
| LCDD (mm) | 51.35 ± 3.97 | 56.05 ± 3.09 |
| LAD (mm) | 33.45 ± 4.01 | 40.05 ± 4.12 |
Figure 5Comparison on the results of LVEF, LCDD, and LAD diagnosed by using a cardiac color ultrasound between the two groups.
Statistical results of positive rates of cardiac ultrasound in LVEF, LCDD, and LAD in the two groups.
| Indicators | Positive rate ( | |
|---|---|---|
| Control group | Experimental group | |
| LVEF (%) | 56 | 65 |
| LCDD (mm) | 59 | 69 |
| LAD (mm) | 57 | 66 |
Figure 6Comparison on positive rates of LVEF, LCDD, and LAD diagnosed by using a color Doppler ultrasound between the two groups.
Comparison on the results of CHF patients diagnosed from the two groups and the final diagnosis results.
| Symptom | Group | ||
|---|---|---|---|
| Control group | Experimental group | The final diagnosis results | |
| CHF | 200 | 215 | 230 |
| Other diseases | 59 | 44 | 29 |
| CHF proportion | 77.4% | 83.1% | 88.9% |
Figure 7Comparison on the probability of patients with CHF in the three groups.